MRS2690 disodium is a selective agonist of the P2Y14 receptor. It inhibits adenylyl cyclase activity, thereby reducing intracellular cAMP levels and causing concentration-dependent vasoconstriction in porcine coronary arteries. MRS2690 disodium induces intracellular calcium mobilization, activates P38, and stimulates [35S]GTPgammaS binding on the membrane of RBL-2H3 cells. It also enhances the beta-hexosaminidase (beta-Hex) release induced by antigen (NP-BSA) and C3a. This compound is useful for research in ischemic heart disease.
Target-Kategorie:
p38 MAPK|||Calcium Channel|||P2Y Receptor
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
